Literature DB >> 11049185

Monte Carlo dose calculations and radiobiological modelling: analysis of the effect of the statistical noise of the dose distribution on the probability of tumour control.

F M Buffa1, A E Nahum.   

Abstract

The aim of this work is to investigate the influence of the statistical fluctuations of Monte Carlo (MC) dose distributions on the dose volume histograms (DVHs) and radiobiological models, in particular the Poisson model for tumour control probability (tcp). The MC matrix is characterized by a mean dose in each scoring voxel, d, and a statistical error on the mean dose, sigma(d); whilst the quantities d and sigma(d) depend on many statistical and physical parameters, here we consider only their dependence on the phantom voxel size and the number of histories from the radiation source. Dose distributions from high-energy photon beams have been analysed. It has been found that the DVH broadens when increasing the statistical noise of the dose distribution, and the tcp calculation systematically underestimates the real tumour control value, defined here as the value of tumour control when the statistical error of the dose distribution tends to zero. When increasing the number of energy deposition events, either by increasing the voxel dimensions or increasing the number of histories from the source, the DVH broadening decreases and tcp converges to the 'correct' value. It is shown that the underestimation of the tcp due to the noise in the dose distribution depends on the degree of heterogeneity of the radiobiological parameters over the population; in particular this error decreases with increasing the biological heterogeneity, whereas it becomes significant in the hypothesis of a radiosensitivity assay for single patients, or for subgroups of patients. It has been found, for example, that when the voxel dimension is changed from a cube with sides of 0.5 cm to a cube with sides of 0.25 cm (with a fixed number of histories of 10(8) from the source), the systematic error in the tcp calculation is about 75% in the homogeneous hypothesis, and it decreases to a minimum value of about 15% in a case of high radiobiological heterogeneity. The possibility of using the error on the tcp to decide how many histories to run for a given voxel size is also discussed.

Entities:  

Mesh:

Year:  2000        PMID: 11049185     DOI: 10.1088/0031-9155/45/10/318

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  6 in total

Review 1.  Preclinical animal research on therapy dosimetry with dual isotopes.

Authors:  Mark W Konijnenberg; Marion de Jong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-01       Impact factor: 9.236

2.  Modelling the interplay between hypoxia and proliferation in radiotherapy tumour response.

Authors:  J Jeong; K I Shoghi; J O Deasy
Journal:  Phys Med Biol       Date:  2013-06-21       Impact factor: 3.609

3.  Dosimetric Evaluation of the Effect of Receptor Heterogeneity on the Therapeutic Efficacy of Peptide Receptor Radionuclide Therapy: Correlation with DNA Damage Induction and In Vivo Survival.

Authors:  Giulia Tamborino; Julie Nonnekens; Marijke De Saint-Hubert; Lara Struelens; Danny Feijtel; Marion de Jong; Mark W Konijnenberg
Journal:  J Nucl Med       Date:  2021-04-09       Impact factor: 11.082

4.  Maintaining dosimetric quality when switching to a Monte Carlo dose engine for head and neck volumetric-modulated arc therapy planning.

Authors:  Vladimir Feygelman; Kujtim Latifi; Mark Bowers; Kevin Greco; Eduardo G Moros; Max Isacson; Agnes Angerud; Jimmy Caudell
Journal:  J Appl Clin Med Phys       Date:  2022-02-25       Impact factor: 2.243

5.  Impact of dose and sensitivity heterogeneity on TCP.

Authors:  Kristin Wiklund; Iuliana Toma-Dasu; Bengt K Lind
Journal:  Comput Math Methods Med       Date:  2014-05-12       Impact factor: 2.238

6.  Recommended dose voxel size and statistical uncertainty parameters for precision of Monte Carlo dose calculation in stereotactic radiotherapy.

Authors:  Simon K Goodall; Martin A Ebert
Journal:  J Appl Clin Med Phys       Date:  2020-10-30       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.